Oncology Central

Ten-gene biomarker panel: a new hope for ovarian cancer?

0

Survival rates for advanced stage ovarian cancer have not changed significantly over the past 40 years and ovarian cancer remains the most lethal gynecologic cancer in women. The most common type of ovarian cancer, and the one that accounts for the majority of deaths from ovarian cancer, is serous papillary carcinoma. Approximately 20% of patients with this ovarian cancer subtype are intrinsically resistant to chemotherapy or develop chemoresistant disease within 1 year from initial treatment.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.